EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.4.1.65 | Fucalpha(1-2)Galbeta(1-3)GlcNAcbeta(1-)(CH2)3-NHCO-(CH2)5-NH-biotin + GDP-L-fucose |
- |
Homo sapiens |
Fucalpha(1-2)Galbeta(1-3)[Fucalpha(1-4)]GlcNAcbeta(1-)(CH2)3-NHCO-(CH2)5-NH-biotin + GDP |
- |
? |
2.4.1.65 | Fucalpha(1-2)Galbeta(1-4)GlcNAcbeta(1-)(CH2)3-NHCO-(CH2)5-NH-biotin + GDP-L-fucose |
- |
Homo sapiens |
Fucalpha(1-2)Galbeta(1-4)[Fucalpha(1-3)]GlcNAcbeta(1-)(CH2)3-NHCO-(CH2)5-NH-biotin + GDP |
- |
? |
2.4.1.65 | Galbeta(1-3)GlcNAcbeta(1-)(CH2)3-NHCO-(CH2)5-NH-biotin + GDP-L-fucose |
- |
Homo sapiens |
Galbeta(1-3)[Fucalpha(1-4)]GlcNAcbeta(1-)(CH2)3-NHCO-(CH2)5-NH-biotin + GDP |
- |
? |
2.4.1.65 | Galbeta(1-4)GlcNAcbeta(1-)(CH2)3-NHCO-(CH2)5-NH-biotin + GDP-L-fucose |
- |
Homo sapiens |
Galbeta(1-4)[Fucalpha(1-3)]GlcNAcbeta(1-)(CH2)3-NHCO-(CH2)5-NH-biotin + GDP |
- |
? |
2.4.1.65 | GDP-beta-L-fucose + 3-sulfo-Galbeta1,3GlcNAc |
40% of the activity with Galbeta1,3GlcNAc |
Helicobacter pylori |
? |
- |
? |
2.4.1.65 | GDP-beta-L-fucose + 3-sulfo-Galbeta1,3GlcNAc |
40% of the activity with Galbeta1,3GlcNAc |
Helicobacter pylori NCTC11639 |
? |
- |
? |
2.4.1.65 | GDP-beta-L-fucose + 3-sulfo-Galbeta1,3GlcNAc |
40% of the activity with Galbeta1,3GlcNAc |
Helicobacter pylori UA948 |
? |
- |
? |
2.4.1.65 | GDP-beta-L-fucose + asialofetuin |
- |
Homo sapiens |
GDP + ? |
- |
? |
2.4.1.65 | GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-D-glucosaminyl-R |
- |
Mus musculus |
GDP + beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-R |
- |
? |
2.4.1.65 | GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-D-glucosaminyl-R |
isoform Fut3 predominantly exhibits alpha1-4 fucosyltransferase activity |
Homo sapiens |
GDP + beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-R |
- |
? |